Literature DB >> 3288625

Stabilization of myc proto-oncogene proteins during Friend murine erythroleukemia cell differentiation.

T G Wingrove1, R Watt, P Keng, I G Macara.   

Abstract

A rapid and dramatic decrease in c-myc mRNA has been associated with the differentiation of a variety of cell types and may be a critical step in the maturation process. In this study, we have simultaneously measured steady-state c-myc protein and c-myc mRNA levels in differentiating Friend murine erythroleukemia (MEL) cells. Northern blot analysis of poly(A+) RNA indicated a greater than 85% decrease in c-myc transcripts following a brief exposure to the inducing agents, dimethyl sulfoxide or hypoxanthine. The short half-life of the c-myc protein (approximately 30 min) suggests that its level should fall in a similar fashion. Surprisingly, immunoblots of total cell proteins and immunoprecipitations of 35S-labeled protein revealed that c-myc protein levels remain approximately constant. This unexpected finding was accounted for in part by an increase in the c-myc protein half-life to 75-85 min. Immunoprecipitation of [35S]methionine-labeled proteins also demonstrated that the undifferentiated MEL cell synthesizes equal amounts of two c-myc-related proteins, p59 and p61. In contrast, MEL cell populations in the late stages of differentiation express predominantly the higher molecular weight species. This latter observation represents the first report of a temporal shift in the relative abundance of the two c-myc isoforms during cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288625

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Two N-myc polypeptides with distinct amino termini encoded by the second and third exons of the gene.

Authors:  T P Mäkelä; K Saksela; K Alitalo
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

2.  Enhanced translation and increased turnover of c-myc proteins occur during differentiation of murine erythroleukemia cells.

Authors:  G D Spotts; S R Hann
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  The ras-like protein p25rab3A is partially cytosolic and is expressed only in neural tissue.

Authors:  E Burstein; I G Macara
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

4.  Differential binding of nuclear factors to the intron 1 sequences containing the transcriptional pause site correlates with c-myb expression.

Authors:  C D Reddy; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene.

Authors:  D McClinton; J Stafford; L Brents; T P Bender; W M Kuehl
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

6.  Stabilization of c-myc protein in human glioma cells.

Authors:  H Shindo; E Tani; T Matsumuto; T Hashimoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts.

Authors:  J W Han; H Sadowski; D A Young; I G Macara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

Review 8.  Glucocorticoids, oxysterols, and cAMP with glucocorticoids each cause apoptosis of CEM cells and suppress c-myc.

Authors:  E B Thompson; R D Medh; F Zhou; S Ayala-Torres; N Ansari; W Zhang; B H Johnson
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

9.  A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation.

Authors:  M J Birrer; L Raveh; H Dosaka; S Segal
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

10.  Effect of verapamil on cell cycle transit and c-myc gene expression in normal and malignant murine cells.

Authors:  K R Huber; W F Schmidt; E A Thompson; A M Forsthoefel; R W Neuberg; R S Ettinger
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.